contentSlug

type

ContentSlug_ContentQuery

slug

ContentPageContentQuery

content

trendingContent

query ContentSlug_ContentQuery(
  $contentSlug: String!
  $type: [ContentType!]
) {
  ...ContentPageContentQuery_13QmVO
}

fragment CompanyDetails_Content on Content {
  __isContent: __typename
  companies {
    name
    description
    pageUrl
    id
  }
}

fragment ContentBasicInfo on Content {
  __isContent: __typename
  id
  type
  title
  lang
  companies {
    viewerIsFollowing
    id
    name
    pageUrl
  }
  tags {
    viewerIsFollowing
    id
    name
    pageUrl
  }
  ...PublishingDetails
  ...Reactions
}

fragment ContentMetadata on Content {
  __isContent: __typename
  type
  title
  lang
  pageUrl
  alternatePageUrls: translations {
    __typename
    pageUrl
    lang
  }
  imgUrl
  description
  ... on Video {
    liveTime
    videoUrl
  }
  ... on Webcast {
    liveTime
    videoUrl
  }
}

fragment ContentPageContentQuery_13QmVO on Query {
  content(slug: $contentSlug, type: $type) {
    __typename
    id
    type
    title
    isPremium
    lang
    htmlBody
    summary
    companies {
      forum {
        latestPosts {
          ...ForumPosts
        }
      }
      name
      id
      viewerIsFollowing
      pageUrl
      defaultInstrument {
        isin
        id
        marketOpen
        marketClose
        marketplace {
          region
        }
        returns {
          total
        }
      }
    }
    tags {
      viewerIsFollowing
      id
      name
      pageUrl
    }
    createdAt
    ... on Video {
      liveTime
    }
    ... on Webcast {
      liveTime
    }
    slug
    ... on CompanyReport {
      reportUrl
    }
    ... on ThirdPartyCompanyReport {
      reportUrl
    }
    ... on StockExchangeRelease {
      reportUrl
    }
    ...ContentBasicInfo
    ...ContentMetadata
    ...PriceAndRecommendation_Content
    ...CompanyDetails_Content
    ...ReportLink_Content
    ...KeyFigures_Content
  }
  ...TrendingContent_1jQ2Cn
}

fragment ForumPosts on ForumPost {
  text
  likesCount
  url
  author
  postedAt
  authorImgUrl
}

fragment KeyFigures_Content on Content {
  __isContent: __typename
  companies {
    defaultInstrument {
      estimateData {
        modelType
        reportingCurrency
      }
      snapshot {
        transaction {
          date
          actualized {
            year
            quarter
            revenue
            revenueGrowth
            ebitAdjusted
            ebitReported
            ebitda
            enterpriseValue
            epsAdjusted
            dividend
            dividendYield
            sharePrice
          }
          estimates {
            year
            quarter
            revenue
            revenueGrowth
            ebitAdjusted
            ebitReported
            ebitda
            enterpriseValue
            epsAdjusted
            dividend
            dividendYield
            sharePrice
          }
        }
      }
      id
    }
    id
  }
}

fragment PriceAndRecommendation_Content on Content {
  __isContent: __typename
  createdAt
  companies {
    name
    pageUrl
    defaultInstrument {
      priceData {
        tradeCurrency
      }
      snapshot {
        priceData {
          date
          lastPrice
          tradeCurrency
        }
        transaction {
          date
          recommendation
          targetPrice
        }
        prevTransaction {
          recommendation
        }
      }
      id
    }
    id
  }
}

fragment PublishingDetails on Content {
  __isContent: __typename
  createdAt
  publishers {
    name
    imgUrl
  }
  authors {
    __typename
    id
    name
    slug
    imgUrl
    jobTitle
  }
  ... on Video {
    liveTime
  }
  ... on Webcast {
    liveTime
  }
}

fragment Reactions on Content {
  __isContent: __typename
  id
  reactionGroups {
    reactionType
    reactionsCount
    viewerReacted
  }
}

fragment ReportLink_Content on Content {
  __isContent: __typename
  type
  isPremium
  ... on CompanyReport {
    reportUrl
  }
  ... on ThirdPartyCompanyReport {
    reportUrl
  }
  ... on StockExchangeRelease {
    reportUrl
  }
}

fragment TrendingContent_1jQ2Cn on Query {
  trendingContent(type: ARTICLE) {
    __typename
    id
    title
    lang
    pageUrl
    createdAt
    type
    imgUrl
    companies {
      squareLogoUrl
      name
      id
    }
    authors {
      __typename
      imgUrl
      id
    }
    publishers {
      imgUrl
    }
  }
}


vitrolife-ab-publ-vitrolife-announces-genetic-services-restructuring-program-targeting-annualised-savings-of-65-msek-and-recognises-a-54-bsek-goodwill-impairment

__typename

title

isPremium

lang

htmlBody

summary

companies

createdAt

publishers

authors

reactionGroups

pageUrl

translations

imgUrl

description

Vitrolife är en internationell koncern som tillhandahåller medicintekniska produkter och genetiska tjänster. Bolaget utvecklar och tillverkar tjänster och produkter för individanpassad genetisk information samt medicintekniska produkter inom fertilitet. Vitrolife stödjer kunderna i deras verksamhet för att förbättra patienternas utkomst av fertilitetsbehandlingar. Vitrolifes produkter och tjänster finns tillgängliga globalt. Bolaget har sitt huvudkontor i Göteborg, Sverige.

Vitrolife

Vitrolife AB (publ) ("Vitrolife") today announced that following a strategic review it will execute a restructuring program of its genetic services business. The program is targeting annualised...

<div class="abstract">Vitrolife AB (publ) ("Vitrolife") today announced that following a strategic review it will execute a restructuring program of its genetic services business. The program is targeting annualised savings of SEK 65 million, expected to have a positive impact in the first half of 2026, and to reach full effect by the end of the third quarter 2026. Furthermore, Vitrolife will record a goodwill impairment of SEK 5.4 billion in Q4 2025, related to the Igenomix acquisition.</div>As part of the restructuring program, Vitrolife has decided to discontinue two genetic test lines (GPDx and NACE). An agreement has been reached with Unilabs to ensure continued access to these genetic services for selected customers. Vitrolife will in addition exit low profit markets within the genetic services business to concentrate on tests and markets that offer profitable growth potential. Together, GPDx, NACE and low-profit markets account for approximately 2-3% of the Group's revenue.&nbsp;The restructuring program will impact approximately 6% of Vitrolife's workforce incurring restructuring costs of SEK 55 million which will be recorded in the fourth quarter of 2025. The program is targeting annualised savings of SEK 65 million, expected to have a positive impact in the first half of 2026, and to reach full effect at the end of the third quarter of 2026. &nbsp;As a result of the strategic review, Vitrolife will, in accordance with IFRS accounting standards, record a SEK 5.4 billion impairment in Q4 2025 relating to goodwill associated with the Igenomix acquisition. The write-down will not impact cash flow. The impairment is a consequence of the outcome of the strategic review showing lower than expected market growth for parts of the genetic services product portfolio and an increased discount factor (WACC). &nbsp;"Over the past two years, we have successfully brought the genetic services business to growth and improved profitability. With today's decisions we will increase focus and lay the foundation for further improvements in the financial performance of genetic services," says Bronwyn Brophy O'Connor, CEO of the Vitrolife Group.&nbsp;Gothenburg, 16 December, 2025  &nbsp; VITROLIFE AB (publ) &nbsp;&nbsp; Bronwyn Brophy O'Connor, CEO <div>This disclosure contains information that Vitrolife AB (publ) is obliged to make public pursuant to the EU Market Abuse Regulation (EU nr 596/2014). The information was submitted for publication, through the agency of the contact person, on 16-12-2025 19:02 CET.</div>

Vitrolife AB (publ): Vitrolife announces genetic services restructuring program targeting annualised savings of 65 MSEK and recognises a 5.4 BSEK goodwill impairment